# Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

> **NCT06357182** · PHASE1 · RECRUITING · sponsor: **OHSU Knight Cancer Institute** · enrollment: 24 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndrome/Acute Myeloid Leukemia

## Interventions

- **DRUG:** Azacitidine
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bone Marrow Biopsy
- **PROCEDURE:** Echocardiography Test
- **DRUG:** Iadademstat
- **PROCEDURE:** Multigated Acquisition Scan
- **OTHER:** Questionnaire Administration
- **DRUG:** Venetoclax

## Key facts

- **NCT ID:** NCT06357182
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-22
- **Primary completion:** 2026-03-08
- **Final completion:** 2026-05-29
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06357182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06357182, "Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06357182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*